June 4: Ebus in staging lung cancer

V. Ninane (Brussels, Belgium)

Source:
Number: 10
Disease area: Thoracic oncology

Multimedia filesSlide presentation

Rating: 1
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Ninane (Brussels, Belgium). June 4: Ebus in staging lung cancer. 2008

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Validation of the TNM classification (6th ed. / 2003) in the staging of small-cell lung cancer (SCLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 163s
Year: 2003

Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


Staging of lung cancer
Source: Eur Respir Mon; 2009: 44: 150–168
Year: 2009

Lung cancer: screening and staging
Source: Eur Respir Monogr 2015; 70: 47-59
Year: 2015


Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Lung cancer: staging with respect to the new 8th TNM-classification
Source: International Congress 2018 – Imaging Grand Round
Year: 2018


Current surgical treatment of nonsmall cell lung cancer 2001
Source: Eur Respir J 2002; 19: 61S-70S
Year: 2002



Extrathoracic 18-FDG-PET uptakes in non small cell lung cancer (NSCLC) preoperative staging
Source: Eur Respir J 2007; 30: Suppl. 51, 430s
Year: 2007

Major changes in men with non-small-cell lung cancer (NSCLC) in 10 years: The KBP-2000-CPHG and KBP-2010-CPHG cohorts
Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Year: 2013



Is primary tumor metabolic activity a risk factor for occult lymph node metastasis in T1-2N0M0 non-small cell lung cancer patients?
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014

Intrathoracic lymph node staging of potentially resectable non-small cell lung cancer - The role of PET-CT
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015


Ultrasound guided true cut biopsy of peripheral lymph nodes as a staging procedure in patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – EBUS and transthoracic ultrasound
Year: 2016


An algorithm for lung cancer staging
Source: School Course 2014- Endoscopic ultrasound in the diagnosing and staging of lung cancer
Year: 2014


Survival trend of patients with lung cancer (LC) in Cáceres (Spain) (1991-2003). Analysis based on TNM staging, histology, modality-treatment and time-period of diagnosis
Source: Eur Respir J 2007; 30: Suppl. 51, 669s
Year: 2007

Quality indicators in lung cancer care-review of resection rates in early stage NSCLC (non small cell lung cancer) at King’s
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018

Comparison of non-small cell lung cancer (NSCLC) management and survival in 1995 and 2005 at a London teaching hospital
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008


Epidemiology, diagnosis, classification and staging of lung cancer
Source: Annual Congress 2011 - PG10 Management of thoracic tumours in practice: a HERMES basic course
Year: 2011